Development and analytical performance of an automated screening method for cannabinoids on the Dimension(R) clinical chemistry system
1997

Automated Screening Method for Cannabinoids

Sample size: 445 publication Evidence: high

Author Information

Author(s): D. M. Obzansky, E. G. Gorman, S. P. Kramer, I. S. Masulli, E. A. Nuzzaci, W. F. Skogen

Primary Institution: Dade Chemistry Systems Inc.

Hypothesis

The study aims to develop a fully automated method for the determination of cannabinoids using the Dimension clinical chemistry system.

Conclusion

The developed method provides a precise, accurate, and rapid screening approach for measuring cannabinoids.

Supporting Evidence

  • The method demonstrated a within-run reproducibility of less than 0.6% CV.
  • Calibration stability was retained for at least 30 days.
  • A 99.1% agreement was found between the new method and an existing EMIT-based method.

Takeaway

This study created a new way to quickly test for marijuana in urine samples using a machine, making it easier for hospitals to check for drug use.

Methodology

The method was evaluated for reproducibility, calibration stability, and specificity using various drug-free urine samples and known cannabinoid concentrations.

Limitations

The study does not specify the potential for false positives or negatives in detail.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication